Ali Ziya KARAKILÇIK, Muharrem BİTİREN, Mustafa ZERİN, Hakim ÇELİK, Nurten AKSOY

Melatonin increased vitamin C and antioxidant enzyme values in the plasma,heart, liver, and kidney of Adriamycin-treated rats

Adriamycin, an anticarcinogenic agent, causes excessive production of reactive oxygen species (ROS). These radicals may affect antioxidant defense systems. The present study was designed to investigate the effects of melatonin on antioxidant enzyme activities and vitamin C in Adriamycin-treated rats. In the current study, rats were divided into three groups: control, Adriamycin, and melatonin+Adriamycin groups. The control group was intraperitoneally injected physiological saline (0.9%) as a placebo. The Adriamycin and melatonin+Adriamycin groups were administered Adriamycin (25 mg/kg body weight). The melatonin+Adriamycin group was pretreated with melatonin (0.5 mg/kg body weight). Vitamin C concentration and catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), glutathione reductase (GR), and myeloperoxidase (MPO) activities were determined in the plasma, heart, liver, and kidneys in the Adriamycin-treated rats. The activities of CAT, SOD, GSH-Px, GR, and MPO decreased generally (between P < 0.045 and P < 0.006) with Adriamycin treatment, but these enzymes were near to the control values with melatonin treatment. In conclusion, melatonin inhibited Adriamycin-induced ROS production through supporting antioxidant enzyme systems in the plasma, heart, liver, and kidneys of rats, and thus may play an important role against Adriamycin toxicity.

Anahtar Kelimeler:

Adriamycin, melatonin, antioxidant enzymes, heart, liver, kidney, rat

Melatonin increased vitamin C and antioxidant enzyme values in the plasma, heart, liver, and kidney of Adriamycin-treated rats

Keywords:

Adriamycin, melatonin, antioxidant enzymes, heart, liver, kidney, rat,

PDF

___

Agapito MT, Antolin Y, Del Brio MT, López-Burillo S, Pablos MI, Recio JM (2001). Protective effect of melatonin against adriamycin toxicity in the rat. J Pineal Res 31: 23–30.
Aydogan MS, Erdogan MA, Polat A, Yucel A, Ozgul U, Parlakpinar H, Duran ZR, Yildiz A, Durmus M (2013). Protective effects of melatonin and β-d-glucan against liver injury in rats – a comparative study. Adv Clin Exp Med 22: 621–627.
Berthiaume JM, Wallace KB (2007). Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol 23: 15–25.
Bilginoğlu A, Aydın D, Özsoy Ş, Aygün H (2014). Protective effect of melatonin on adriamycin-induced cardiotoxicity in rats. Arch Turk Soc Cardiol 42: 265–273.
Bubenik GA (2002). Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47: 2336–2348.
Carlberg I, Mannervik B (1986). Reduction of 2,4,6-trinitro- benzenesulfonate by glutathione reductase and the effect of NADP+ on the electron transfer. J Biol Chem 261: 1629–1635.
Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, Garcia-Maurino S, Reiter RJ, Guerrero JM (2004). Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 18: 537–539.
Conti, A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni JM (2000). Evidence for melatonin synthesis in mouse and human bone marrow cells. J Pineal Res 28: 193–202.
Elberry AA, Abdel-Naim AB, Abdel-Sattar EA, Nagy AA, Mosli HA, Mohamadin AM, Ashour OM (2010). Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol 48: 1178–1184.
Escribano BM, Moreno A, Tasset I, Tunez I (2014). Impact of light/ dark cycle patterns on oxidative stress in an adriamycin- induced nephropathy model in rats. PLoS ONE 9: e97713.
Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC (2005). Cardiotoxicity of cancer therapy. J Clin Oncol 23: 7685–7696.
Gewirtz DA (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727–741.
Goth L (1991). A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 196: 143–152.
Guano F, Pourquier P, Tinelli S, Binaschi M, Bigioni M, Animati F, Manzini S, Zunino F, Kohlhagen G, Pommier Y et al. (1999). Topoisomerase poisoning activity of novel disaccharide anthracyclines. Mol Pharmacol 56: 77–84.
Hrenak J, Arendasova K, Rajkovicova R, Aziriova S, Repova K, Krajcirovicova K, Celec P, Kamodyova N, Barta A, Adamcova M et al (2013). Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats. Physiol Res 62: 181–189.
Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E, Kotamraju S (2002). Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234–235: 119–124.
Kim C, Kim N, Joo H, Youm JB, Park WS, Cuong DV, Park YS, Kim E, Min CK, Han J (2005). Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin. J Cardiovasc Pharmacol 46: 200–210.
Kiyomiya K, Matsuo S, Kurebe M (2001). Differences in intracellular sites of action of adriamycin in neoplastic and normal differentiated cells. Cancer Chemother Pharmacol 47: 51–56.
Koçkar MC, Nazıroğlu M, Çelik Ö, Tola HT, Bayram D, Koyu A (2010). N-acetylcysteine modulates doxorubicin-induced oxidative stress and antioxidant vitamin concentrations in liver of rats. Cell Biochem Funct 28: 673–677.
Krawisz JE, Sharon P, Stenson WF (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344–1350.
Lee IC, Kim SH, Baek HS, Moon C, Bae CS, Kim SH, Yun WK, Nam KH, Kim HC, Kim JC (2013). Melatonin improves adriamycin- induced hepatic oxidative damage in rats. Mol Cell Toxicol 9: 257–265.
Lowry O, Rosenbraugh N, Farr L, Rondall RJ (1951). Protein measurement with the folin-phenol reagent. J Biol Chem 193: 265–275.
Monti E, Cova D, Guido E, Morelli R, Oliva C (1996). Protective effects of the nitroxide tempol against the cardiotoxicity of adriamycin. Free Radic Biol Med 21: 463–470.
Nazıroğlu M (2007). New molecular mechanisms on the activation of TRPM2 channels by 23 oxidative stress and ADP-ribose. Neurochem Res 32: 1990–2001.
Nazıroğlu M (2009). Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy. Neurochem Res 34: 2181–2191.
Nazıroğlu M (2015). Role of melatonin on calcium signaling and mitochondrial oxidative stress in epilepsy: focus on TRP channels. Turk J Biol in press.
Naziroğlu M, Tokat S, Demirci S (2012). Role of melatonin on electromagnetic radiation-induced oxidative stress and Ca2+ signaling molecular pathways in breast cancer. J Recept Signal Transduct Res 32: 290–297.
Omaye ST, Turnbull JD, Sauberlich HE (1979). Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62: 3–11.
Othman AI, El-Missiry MA, Amer MA, Arafa M (2008). Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats. Life Sci 83: 563– 568.
Özdoğan K, Taşkın E, Dursun N (2011). Protective effect of carnosine on adriamycin-induced oxidative heart damage in rats. Anatol J Cardiol 1: 3–10.
Paglia DE, Valentine WN (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158–170.
Reiter RJ, Tang L, Garcia JJ, Munoz-Hoyos A (1997). Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60: 2255–2271.
Senol N, Nazıroğlu M (2014). Melatonin reduces traumatic brain injury-induced oxidative stress in the cerebral cortex and blood of rats. Neural Regen Res 9: 1112–1116.
Slominski A, Fischer TW, Zmijewski MA, Wortsman J, Semak I, Zbytek B, Slominski RM, Tobin DJ (2005). On the role of melatonin in skin physiology and pathology. Endocrine 27: 137–148.
Sun Y, Oberley L, Li Y (1988). A simple method for clinical assay of superoxide dismutase. Clin Chem 34: 497–500.
Tan DX, Manchester LC, Reiter RJ, Plommer BF, Hardies LJ, Weintraub ST, Vijayalaxmi A, Shepherd M (1998). A novel melatonin metabolite, cyclic 3-hydroxymelatonin; a biomarker of melatonin interaction with hydroxyl radicals. Biochem Biophys Res Commun 253: 614–620.
Tosini G, Menaker M (1998). The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration. Brain Res 789: 221–228.
Uguz AC, Cig B, Espino J, Bejarano I, Naziroglu M, Rodríguez AB, Pariente JA (2012). Melatonin potentiates chemotherapy- induced cytotoxicity and apoptosis in rat pancreatic tumor cells. J Pineal Res 53: 91–98.
Van Der Loo B, Bachschmid M, Spitzer V, Brey L, Ullrich V, Luschera TF (2003). Decreased plasma and tissue levels of vitamin C in a rat model of aging: implications for antioxidative defense. Biochem Biophys Res Comm 303: 483–487.
Vora J, Khaw BA, Narula J, Boroujerdi M (1996). Protective effect of butylated hydroxyanisole on adriamycin induced cardiotoxicity. J Pharm Pharmacol 48: 940–944.
Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M (2001). Prevention of neutrophil- mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther 298: 894–899.
Zerin M, Karakılçık AZ, Bitiren M, Musa D, Özgönül A, Selek Ş, Nazlıgül Y, Uzunköy A (2010). Vitamin C modulates oxidative stress-induced colitis in rats. Turk J Med Sci 40: 871–879.
Zhang Y, Li L, Xiang C, Ma Z, Ma T, Zhu S (2013). Protective effect of melatonin against adriamycin-induced cardiotoxicity. Exp Therap Med 5: 1496–1500.